These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

787 related articles for article (PubMed ID: 20142114)

  • 21. [Usefulness of B-type natriuretic peptide (BNP) for the diagnosis of new-onset heart failure with a preserved left ventricular systolic function in longstanding hypertensive patients with acute dyspnea].
    Arquès S; Roux E; Sbragia P; Pieri B; Gélisse R; Luccioni R; Ambrosi P
    Arch Mal Coeur Vaiss; 2007 Feb; 100(2):113-20. PubMed ID: 17474496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. B-type natriuretic peptide and echocardiographic determination of ejection fraction in the diagnosis of congestive heart failure in patients with acute dyspnea.
    Steg PG; Joubin L; McCord J; Abraham WT; Hollander JE; Omland T; Mentré F; McCullough PA; Maisel AS
    Chest; 2005 Jul; 128(1):21-9. PubMed ID: 16002911
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Left atrial volume index in patients with heart failure and severely impaired left ventricular systolic function: the role of established echocardiographic parameters, circulating cystatin C and galectin-3.
    Zivlas C; Triposkiadis F; Psarras S; Giamouzis G; Skoularigis I; Chryssanthopoulos S; Kapelouzou A; Ramcharitar S; Barnes E; Papasteriadis E; Cokkinos D
    Ther Adv Cardiovasc Dis; 2017 Nov; 11(11):283-295. PubMed ID: 28830298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determinants of left atrial volume index in patients with aortic stenosis: A multicentre pilot study.
    Rusinaru D; Bohbot Y; Salaun E; Donal E; Calsata AC; Galli E; Lavoute C; Fournet M; Szymanski C; Leclercq C; Habib G; Tribouilloy C
    Arch Cardiovasc Dis; 2017 Oct; 110(10):525-533. PubMed ID: 28566199
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Left atrial volume index is critical for the diagnosis of heart failure with preserved ejection fraction.
    Almeida P; Rodrigues J; Lourenço P; Maciel MJ; Bettencourt P
    J Cardiovasc Med (Hagerstown); 2018 Jun; 19(6):304-309. PubMed ID: 29553992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic accuracy and clinical utility of echocardiographic indices for detecting left ventricular diastolic dysfunction in patients with coronary artery disease and normal ejection fraction.
    Ozer N; Okutucu S; Kepez A; Aksoy H; Deveci OS; Atalar E; Ovünç K; Aksöyek S
    Anadolu Kardiyol Derg; 2011 Dec; 11(8):666-73. PubMed ID: 22037100
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relation of left ventricular end-diastolic pressure and N-terminal pro-brain natriuretic peptide level with left atrial deformation parameters.
    Kurt M; Tanboga IH; Aksakal E; Kaya A; Isik T; Ekinci M; Bilen E
    Eur Heart J Cardiovasc Imaging; 2012 Jun; 13(6):524-30. PubMed ID: 22166592
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New, simple echocardiographic indexes for the estimation of filling pressure in patients with cardiac disease and preserved left ventricular ejection fraction.
    Dokainish H; Nguyen J; Sengupta R; Pillai M; Alam M; Bobek J; Lakkis N
    Echocardiography; 2010 Sep; 27(8):946-53. PubMed ID: 20849482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of left ventricular systolic function using echocardiography in patients with preserved ejection fraction and elevated diastolic pressures.
    Dokainish H; Sengupta R; Pillai M; Bobek J; Lakkis N
    Am J Cardiol; 2008 Jun; 101(12):1766-71. PubMed ID: 18549856
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relation of left atrial volume to B-type natriuretic peptide levels in patients with stable chronic heart failure.
    Barclay JL; Kruszewski K; Croal BL; Cuthbertson BH; Oh JK; Hillis GS
    Am J Cardiol; 2006 Jul; 98(1):98-101. PubMed ID: 16784929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Carvedilol on Serum Heart-type Fatty Acid-binding Protein, Brain Natriuretic Peptide, and Cardiac Function in Patients With Chronic Heart Failure.
    Sun YP; Wei CP; Ma SC; Zhang YF; Qiao LY; Li DH; Shan RB
    J Cardiovasc Pharmacol; 2015 May; 65(5):480-4. PubMed ID: 25945865
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictive value of B-type natriuretic peptides in detecting latent left ventricular diastolic dysfunction in beta-thalassemia major.
    Kremastinos DT; Hamodraka E; Parissis J; Tsiapras D; Dima K; Maisel A
    Am Heart J; 2010 Jan; 159(1):68-74. PubMed ID: 20102869
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early diagnosis of congestive heart failure: clinical utility of B-type natriuretic peptide testing associated with Doppler echocardiography.
    Aspromonte N; Feola M; Scardovi AB; Coletta C; D'Eri A; Giovinazzo P; Carunchio A; Chiera A; Fanelli R; Di Giacomo T; Ricci R; Ceci V; Milani L; Valle R
    J Cardiovasc Med (Hagerstown); 2006 Jun; 7(6):406-13. PubMed ID: 16721202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Left atrial volume index over late diastolic mitral annulus velocity (LAVi/A') is a useful echo index to identify advanced diastolic dysfunction and predict clinical outcomes.
    Park HJ; Jung HO; Min J; Park MW; Park CS; Shin DI; Shin WS; Kim PJ; Youn HJ; Seung KB
    Clin Cardiol; 2011 Feb; 34(2):124-30. PubMed ID: 21298657
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of B-type natriuretic peptide with left atrial enlargement by echocardiography for the diagnosis of new-onset congestive heart failure with a preserved left ventricular systolic function in the setting of longstanding hypertension.
    Arques S; Roux E; Sbragia P; Pieri B; Gelisse R; Luccioni R; Ambrosi P
    Int J Cardiol; 2008 Aug; 128(1):123-5. PubMed ID: 17659793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
    Grewal J; McKelvie RS; Persson H; Tait P; Carlsson J; Swedberg K; Ostergren J; Lonn E
    Am J Cardiol; 2008 Sep; 102(6):733-7. PubMed ID: 18773998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Baseline characteristics of patients with heart failure and preserved ejection fraction included in the Karolinska Rennes (KaRen) study.
    Donal E; Lund LH; Oger E; Hage C; Persson H; Reynaud A; Ennezat PV; Bauer F; Sportouch-Dukhan C; Drouet E; Daubert JC; Linde C;
    Arch Cardiovasc Dis; 2014 Feb; 107(2):112-21. PubMed ID: 24388161
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early predictors of myocardial disease in children and adolescents with type 1 diabetes mellitus.
    Salem M; El Behery S; Adly A; Khalil D; El Hadidi E
    Pediatr Diabetes; 2009 Dec; 10(8):513-21. PubMed ID: 19708908
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Possible role of BNP for an early diagnosis of asymptomatic left ventricular dysfunction: a retrospective study.
    De Vecchis R; Esposito C; Ariano C; Di Biase G
    Minerva Cardioangiol; 2014 Apr; 62(2):147-59. PubMed ID: 24686994
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Type B natriuretic peptide in the diagnosis of heart failure with preserved systolic function].
    Castro A; Dias P; Pereira M; Pimenta J; Friões F; Rodrigues R; Ferreira A; Bettencourt P
    Rev Port Cardiol; 2001 Nov; 20(11):1109-13. PubMed ID: 11826702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.